Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
New York, USA, June 23, 2026 (GLOBE NEWSWIRE) -- Acute Kidney Injury Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight ...
-
New York, USA, June 22, 2026 (GLOBE NEWSWIRE) -- Cutaneous Lupus Erythematosus Market to Expand at a CAGR of 8% During the Forecast Period (2026–2036) Amid Emerging Therapies and Increasing...
-
New York, USA, June 18, 2026 (GLOBE NEWSWIRE) -- Global Cell and Gene Therapy CDMO Market Anticipating Remarkable Growth at a CAGR of ~24% by 2034 | DelveInsight The cell and gene therapy CDMO...
-
New York, USA, June 18, 2026 (GLOBE NEWSWIRE) -- Age-related Macular Degeneration Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 90+ Leading Players...
-
New York, USA, June 16, 2026 (GLOBE NEWSWIRE) -- Glioblastoma Clinical Trial Landscape Expands: Over 200 Companies Advancing Next-Generation Therapies | DelveInsight The glioblastoma clinical trial...
-
New York, USA, June 15, 2026 (GLOBE NEWSWIRE) -- Osteoarthritis Market Expected to Showcase Moderate Growth at a CAGR of 3% During the Forecast Period (2026–2036) Driven by Emerging Therapies and...
-
New York, USA, June 10, 2026 (GLOBE NEWSWIRE) -- Metastatic Prostate Cancer Market Set for Robust Growth Through 2036, Driven by The Emergence of PARP Inhibitors and PSMA-targeted Radioligand...
-
New York, USA, June 10, 2026 (GLOBE NEWSWIRE) -- Lupus Nephritis Clinical Trial Landscape Becomes Increasingly Crowded with 30+ Pharma Companies | DelveInsight The lupus nephritis clinical trial...
-
New York, USA, June 09, 2026 (GLOBE NEWSWIRE) -- Treg Cell-Based Therapies Clinical Trial Pipeline Appears Robust With 29+ Key Pharma Companies Actively Working in the Domain | DelveInsight The...
-
New York, USA, June 08, 2026 (GLOBE NEWSWIRE) -- Alcohol Use Disorder Market Set to Expand at a 12.1% CAGR During the Forecast Period (2026–2036), Owing to the Emergence of Novel Mechanisms Such as...